Glenmark Life Sciences Limited, a subsidiary of Glenmark Pharmaceuticals Limited, is a Mumbai-based company that specializes in the development, manufacturing, and supply of non-commoditized active pharmaceutical ingredients (APIs) in India. The company focuses on producing APIs for various chronic therapeutic areas.
Glenmark Life Sciences offers a wide range of APIs for different diseases. For cardiovascular diseases, they provide medications such as Olmesartan, Amiodarone, Telmisartan, Perindopril, Rosuvastatin, and Cilostazol. In the field of central nervous system diseases, they offer Oxcarbazepine, Zonisamide, Topiramate, Bupropion, Ropinirole, Riluzole, and Lacosamide. For diabetes, they provide Glimepiride, Teneligliptin, Vildagliptin, and Linagliptin. Additionally, they offer Etoricoxib and Lornoxicam for pain management, and Atovaquone, Voriconazole, Mirabegron, Desloratadine, Esomeprazole Magnesium, Adapalene, and Fluconazole for gastro-intestinal disorders, anti-infective, respiratory, anti-emetic, and other therapeutic areas.
Apart from API production, Glenmark Life Sciences also offers contract development and manufacturing services to multinational pharmaceutical and specialty pharmaceutical companies. They have a global presence and export their products to Europe, North America, Latin America, Japan, and other international markets.
Glenmark Life Sciences Limited was established in 2011 and has since become a prominent player in the pharmaceutical industry in India.
Glenmark Life Sciences offers a wide range of APIs for different diseases. For cardiovascular diseases, they provide medications such as Olmesartan, Amiodarone, Telmisartan, Perindopril, Rosuvastatin, and Cilostazol. In the field of central nervous system diseases, they offer Oxcarbazepine, Zonisamide, Topiramate, Bupropion, Ropinirole, Riluzole, and Lacosamide. For diabetes, they provide Glimepiride, Teneligliptin, Vildagliptin, and Linagliptin. Additionally, they offer Etoricoxib and Lornoxicam for pain management, and Atovaquone, Voriconazole, Mirabegron, Desloratadine, Esomeprazole Magnesium, Adapalene, and Fluconazole for gastro-intestinal disorders, anti-infective, respiratory, anti-emetic, and other therapeutic areas.
Apart from API production, Glenmark Life Sciences also offers contract development and manufacturing services to multinational pharmaceutical and specialty pharmaceutical companies. They have a global presence and export their products to Europe, North America, Latin America, Japan, and other international markets.
Glenmark Life Sciences Limited was established in 2011 and has since become a prominent player in the pharmaceutical industry in India.
